Alimta-H-C-PSUSA-00002330-202402: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Alimta-H-C-PSUSA-00002330-202402: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Alimta-H-C-PSUSA-00002330-202402: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Stärke
Alimta-H-C-PSUSA-00002330-202402: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Packungsgröße
Alimta-H-C-PSUSA-00002330-202402: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Form
Alimta-H-C-PSUSA-00002330-202402: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Quelle
European Medicines Agency
Sicherheitsprofil
Kontraindikationen
Nebenwirkungen
Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.